Logo image
Se connecter
Patients With Moderate-to-Severe Asthma Receiving Dupilumab Are More Likely to Meet 4 Key Clinical Remission Criteria: Results From the VESTIGE Trial
Article de revue   Avec comité de lecture

Patients With Moderate-to-Severe Asthma Receiving Dupilumab Are More Likely to Meet 4 Key Clinical Remission Criteria: Results From the VESTIGE Trial

Mario Castro, Njira Lugogo, Alberto Papi, Celeste Porsbjerg, Christopher Brighling, Arnaud Bourdin, Cláudia Loureiro, Mei Zhang, Xavier Soler et Hashem Awad
Journal of allergy and clinical immunology, Vol.155(2), pp.AB231-AB231
02/2025

Indicateurs

1 Consultations de la notice

Détails

Logo image